MMS logo
MMS
Maximus

Extended CMS And VA Contracts And Tech Modernization Opportunities Will Strengthen Future Prospects

AN
AnalystConsensusTarget
AnalystConsensusTarget
Not Invested
Consensus Narrative from 2 Analysts
Published
29 Aug 24
Updated
07 Aug 25
AnalystConsensusTarget's Fair Value
US$103.00
20.9% undervalued intrinsic discount
07 Aug
US$81.45
Loading
1Y
-6.1%
7D
11.7%

Author's Valuation

US$103.0

20.9% undervalued intrinsic discount

AnalystConsensusTarget Fair Value

Narrative
Updates9

Shared on07 May 25

Read more

Shared on30 Apr 25
Fair value Increased 1.78%

Read more

Shared on23 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Read more

Shared on17 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Read more

Shared on09 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Read more

Shared on02 Apr 25
Fair value Increased 0.70%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Read more

Shared on26 Mar 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Read more

Shared on19 Mar 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Read more

Shared on10 Mar 25
Fair value Decreased 2.43%

AnalystConsensusTarget has decreased revenue growth from 1.0% to 0.4% and decreased future PE multiple from 23.3x to 18.4x.

Read more